Q2 2022 13F Holders as of 6/30/2022
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
153M
-
Number of holders
-
33
-
Total 13F shares, excl. options
-
3.72M
-
Shares change
-
-422K
-
Total reported value, excl. options
-
$5.99M
-
Value change
-
-$722K
-
Put/Call ratio
-
0.86
-
Number of buys
-
16
-
Number of sells
-
-26
-
Price
-
$1.64
Significant Holders of BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) as of Q2 2022
51 filings reported holding BDSX - BIODESIX INC - Common Stock, par value $0.001 per share as of Q2 2022.
BIODESIX INC - Common Stock, par value $0.001 per share (BDSX) has 33 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 3.72M shares
of 153M outstanding shares and own 2.43% of the company stock.
Largest 10 shareholders include Birchview Capital, LP (1.81M shares), WELLS FARGO & COMPANY/MN (547K shares), Cannell & Co. (206K shares), VANGUARD GROUP INC (180K shares), FRED ALGER MANAGEMENT, LLC (131K shares), Endurant Capital Management LP (131K shares), MILLENNIUM MANAGEMENT LLC (117K shares), GEODE CAPITAL MANAGEMENT, LLC (96.8K shares), MORGAN STANLEY (73.8K shares), and RENAISSANCE TECHNOLOGIES LLC (56.6K shares).
This table shows the top 33 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.